{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:51:06Z","timestamp":1794369066842,"version":"4.9.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11169-x","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:15:36Z","timestamp":1748837736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Carbapenem-resistance in Acinetobacter baumannii: prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-6278","authenticated-orcid":false,"given":"Folasade Muibat","family":"Adeyemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Abiodun","family":"Akinlade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5238-4742","authenticated-orcid":false,"given":"Nana Aishat","family":"Yusuf-Omoloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4642-8486","authenticated-orcid":false,"given":"Olaoniye Habeebat","family":"Ajigbewu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4795-3090","authenticated-orcid":false,"given":"Alabi Peter","family":"Dare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0278-9036","authenticated-orcid":false,"given":"Abideen Akinkunmi","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6815-6162","authenticated-orcid":false,"given":"Omotayo Opemipo","family":"Oyedara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habeeb Salman","family":"Isiaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7076-7059","authenticated-orcid":false,"given":"Alimat Olamide","family":"Usamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"11169_CR1","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3389\/fmicb.2019.01601","volume":"10","author":"FC Morris","year":"2019","unstructured":"Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg A. The mechanisms of disease caused by Acinetobacter baumannii. Front Microbiol. 2019;10:1601.","journal-title":"Front Microbiol"},{"issue":"4","key":"11169_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/pathogens10040387","volume":"10","author":"M Sarshar","year":"2021","unstructured":"Sarshar M, Behzadi P, Scribano D, Palamara AT, Ambrosi C. Acinetobacter baumannii: an ancient commensal with weapons of a pathogen. Pathogens. 2021;10(4):387. https:\/\/doi.org\/10.3390\/pathogens10040387.","journal-title":"Pathogens"},{"key":"11169_CR3","doi-asserted-by":"publisher","unstructured":"Whiteway C, Breine A, Philippe C, Van der Henst C. Acinetobacter baumannii. Trends Microbiol Febr. 2022;30(2). https:\/\/doi.org\/10.1016\/j.tim.2021.11.008","DOI":"10.1016\/j.tim.2021.11.008"},{"key":"11169_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1128\/br.37.4.522-561.1973","volume":"37","author":"SD Henriksen","year":"1973","unstructured":"Henriksen SD. Moraxella, Acinetobacter, and the mimeae. Bacteriol Rev. 1973;37:522\u201361.","journal-title":"Bacteriol Rev"},{"key":"11169_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41426-018-0030-4","volume":"7","author":"NM Elhosseiny","year":"2018","unstructured":"Elhosseiny NM, Attia AS. Acinetobacter: an emerging pathogen with a versatile secretome. Emerg Microbes Infect. 2018;7:1\u201315.","journal-title":"Emerg Microbes Infect"},{"key":"11169_CR6","unstructured":"https:\/\/lpsn.dsmz.de\/genus\/Acinetobacter"},{"issue":"12","key":"11169_CR7","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/jac\/dkx322","volume":"72","author":"J Nowak","year":"2017","unstructured":"Nowak J, Zander E, Stefanik D, Higgins PG, Roca I, Vila J, et al. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J Antimicrob Chemother. 2017;72(12):3277\u201382. https:\/\/doi.org\/10.1093\/jac\/dkx322.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"11169_CR8","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","volume":"48","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;48(10):6987\u201398. https:\/\/doi.org\/10.1007\/s11033-021-06690-6.","journal-title":"Mol Biol Rep"},{"key":"11169_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jinf.2020.10.016","volume":"81","author":"P Gallagher","year":"2020","unstructured":"Gallagher P, Baker S. Developing new therapeutic approaches for treating infections caused by multi-drug-resistant Acinetobacter baumannii: Acinetobacter baumannii therapeutics. J Infect. 2020;81:857\u201361.","journal-title":"J Infect"},{"key":"11169_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fmicb.2020.00775","volume":"11","author":"X Hua","year":"2020","unstructured":"Hua X, Zhang L, He J, Leptihn S, Yu Y. Population biology and epidemiological studies of Acinetobacter baumannii in the era of whole genome sequencing: is the Oxford scheme still appropriate?? Front Microbiol. 2020;11:775.","journal-title":"Front Microbiol"},{"key":"11169_CR11","doi-asserted-by":"publisher","first-page":"e02260","DOI":"10.1128\/mbio.02260-23","volume":"14","author":"C M\u00fcller","year":"2023","unstructured":"M\u00fcller C, Reuter S, Wille J, Xanthopoulou K, Stefanik D, Grundmann H, et al. A global view on carbapenem-resistant Acinetobacter baumannii. mBio. 2023;14:e02260\u201323. https:\/\/doi.org\/10.1128\/mbio.02260-23.","journal-title":"mBio"},{"key":"11169_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","volume":"16","author":"CM Harding","year":"2018","unstructured":"Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16:91\u2013102. https:\/\/doi.org\/10.1038\/nrmicro.2017.148.","journal-title":"Nat Rev Microbiol"},{"key":"11169_CR13","doi-asserted-by":"crossref","unstructured":"Eze EC, Chenia HY, El Zowalaty ME. Acinetobacter baumannii biofilms: Effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018; 11: 2277.","DOI":"10.2147\/IDR.S169894"},{"key":"11169_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/jir.2019.0008","volume":"39","author":"S Pires","year":"2019","unstructured":"Pires S, Parker D. Innate immune responses to Acinetobacter baumannii in the airway. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. 2019;39:441\u20139.","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"11169_CR15","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00253-015-6439-y","volume":"99","author":"J Jung","year":"2015","unstructured":"Jung J, Park W. Acinetobacter species as model microorganisms in environmental microbiology: current state and perspectives. Appl Microbiol Biotechnol. 2015;99:2533\u201348. https:\/\/doi.org\/10.1007\/s00253-015-6439-y.","journal-title":"Appl Microbiol Biotechnol"},{"key":"11169_CR16","doi-asserted-by":"publisher","unstructured":"Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30. https:\/\/doi.org\/10.1128\/cmr.00058-16.","DOI":"10.1128\/cmr.00058-16"},{"key":"11169_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13756-023-01343-8","volume":"12","author":"R Itani","year":"2023","unstructured":"Itani R, Khojah HMJ, Karout S, Rahme D, Hammoud L, Awad R, et al. Acinetobacter baumannii: assessing susceptibility patterns, management practices, and mortality predictors in a tertiary teaching hospital in Lebanon. Antimicrob Resist Infect Control. 2023;12:136. https:\/\/doi.org\/10.1186\/s13756-023-01343-8.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11169_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2017.03.022","volume":"131","author":"MI El-Gamal","year":"2017","unstructured":"El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A. Recent updates of carbapenem antibiotics. Eur J Med Chem. 2017;131:185\u201395. https:\/\/doi.org\/10.1016\/j.ejmech.2017.03.022.","journal-title":"Eur J Med Chem"},{"key":"11169_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","volume":"12","author":"L Poirel","year":"2006","unstructured":"Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12:826\u201336.","journal-title":"Clin Microbiol Infect"},{"key":"11169_CR20","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1128\/AAC.00856-09","volume":"53","author":"PG Higgins","year":"2009","unstructured":"Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53:5035\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"11169_CR21","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1128\/AAC.02413-12","volume":"57","author":"PG Higgins","year":"2013","unstructured":"Higgins PG, P\u00e9rez-Llarena FJ, Zander E, Fern\u00e1ndez A, Bou G, Seifert H. OXA-235, a novel class D \u03b2-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013;57:2121\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"11169_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/iub.532","volume":"63","author":"L Poirel","year":"2011","unstructured":"Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life. 2011;63:1061\u20137.","journal-title":"IUBMB Life"},{"issue":"11","key":"11169_CR23","doi-asserted-by":"publisher","first-page":"4943","DOI":"10.1128\/AAC.00296-11","volume":"55","author":"KM Papp-Wallace","year":"2011","unstructured":"Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55(11):4943\u201360. https:\/\/doi.org\/10.1128\/AAC.00296-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"11169_CR24","doi-asserted-by":"publisher","unstructured":"Odih EE, Oaikhena AO, Underwood A, Hounmanou YMG, Oduyebo OO, Fadeyi A, et al. High genetic diversity and blaNDM-1 prevalence among Acinetobacter baumannii in Nigerian hospitals. mSphere. 2023;8(3). https:\/\/doi.org\/10.1128\/msphere.00098-23.","DOI":"10.1128\/msphere.00098-23"},{"issue":"11","key":"11169_CR25","doi-asserted-by":"publisher","first-page":"e0287762","DOI":"10.1371\/journal.pone.0287762","volume":"18","author":"MT Arowolo","year":"2023","unstructured":"Arowolo MT, Orababa OQ, Olaitan MO, Osibeluwo BV, Essiet UU, Batholomew OH, et al. Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis. PLoS ONE. 2023;18(11):e0287762. https:\/\/doi.org\/10.1371\/journal.pone.0287762.","journal-title":"PLoS ONE"},{"key":"11169_CR26","unstructured":"WHO Bacterial Priority Pathogens List. 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"11169_CR27","unstructured":"CDC. (2024). Antimicrobial Resistance Threats in the United States, 2021\u20132022. 2024. AR_Threats_Report."},{"issue":"11","key":"11169_CR28","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2468-2667(22)00225-0","volume":"7","author":"T Mestrovic","year":"2022","unstructured":"Mestrovic T, Aguilar GR, Swetschinski LR, Ikuta KS, Gray AP, Weaver ND, et al. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross country systematic analysis. Lancet Public Health. 2022;7(11):e897\u2013913. https:\/\/doi.org\/10.1016\/S2468-2667(22)00225-0.","journal-title":"Lancet Public Health"},{"issue":"10325","key":"11169_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"11169_CR30","doi-asserted-by":"publisher","unstructured":"Aguilar GR, Swetschinski LR, Weaver ND, Ikuta KS, Mestrovic T, Gray AP, et al. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis. Lancet Reg Health\u2013Americas. 2023;25. https:\/\/doi.org\/10.1016\/j.lana.2023.100561.","DOI":"10.1016\/j.lana.2023.100561"},{"key":"11169_CR31","doi-asserted-by":"publisher","unstructured":"Ayobami O, Willrich N, Hardera T, Okeke IN, Eckmannsa T, Markwart R. The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern mediterranean and Africa: a systematic review and meta-analysis. Emerg Microbes Infections. 2019;8. https:\/\/doi.org\/10.1080\/22221751.2019.1698273.","DOI":"10.1080\/22221751.2019.1698273"},{"key":"11169_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2020.1775881","author":"DO Ogbolu","year":"2020","unstructured":"Ogbolu DO, Terry Alli OA, Oluremi AS, Ogunjimi YT, Ojebode DI, Dada V, et al. Contribution of NDM and OXA-type carbapenemases to carbapenem resistance in clinical Acinetobacter baumannii from Nigeria. Infect Dis. 2020. https:\/\/doi.org\/10.1080\/23744235.2020.1775881.","journal-title":"Infect Dis"},{"issue":"2","key":"11169_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.34172\/ajcmi.2021.11","volume":"8","author":"FM Adeyemi","year":"2021","unstructured":"Adeyemi FM, Yusuf N-A, Adeboye RR, Oluwajide OO, Ako-Nai AK. Comparative analysis of prevalence and antibiotic resistance in Vancomycin-Resistant Enterococcus from clinical samples\u2013 demographics and phenotypes. Avicenna J Clin Microbiol Infect. 2021a;8(2):57\u201365. https:\/\/doi.org\/10.34172\/ajcmi.2021.11.","journal-title":"Avicenna J Clin Microbiol Infect"},{"issue":"3","key":"11169_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.51585\/gjm.2022.3.0018","volume":"2","author":"SO Ajoseh","year":"2022","unstructured":"Ajoseh SO, Akinyemi KO, Abegunrin RO, Neubauer H, Wareth G. Acinetobacter baumannii from the one health perspective in Nigeria: A systematic review of literature in the last decade (2011\u20132021). Ger J Microbiol. 2022;2(3):12\u201323. https:\/\/doi.org\/10.51585\/gjm.2022.3.0018.","journal-title":"Ger J Microbiol"},{"issue":"10","key":"11169_CR35","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/diagnostics10100832","volume":"10","author":"N Karah","year":"2020","unstructured":"Karah N, Rafei R, Elamin W, Ghazy A, Abbara A, Hamze M, Uhlin BE. Guideline for urine culture and biochemical identification of bacterial urinary pathogens in Low-Resource settings. Diagnostics (Basel Switzerland). 2020;10(10):832. https:\/\/doi.org\/10.3390\/diagnostics10100832.","journal-title":"Diagnostics (Basel Switzerland)"},{"issue":"4","key":"11169_CR36","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4103\/0974-2727.214263","volume":"9","author":"SS Kulkarni","year":"2017","unstructured":"Kulkarni SS, Madalgi R, Ajantha GS, Kulkarni RD. Identification of genus Acinetobacter: standardization of in-house PCR and its comparison with conventional phenotypic methods. J Lab Physicians. 2017;9(4):279\u201382. https:\/\/doi.org\/10.4103\/0974-2727.214263.","journal-title":"J Lab Physicians"},{"issue":"4","key":"11169_CR37","doi-asserted-by":"publisher","first-page":"e114143","DOI":"10.5812\/iji.114143","volume":"8","author":"FM Adeyemi","year":"2021","unstructured":"Adeyemi FM, Yusuf N-A, Adeboye RR, Oyedara OO. Low occurrence of virulence determinants in Vancomycin-Resistant Enterococcus from clinical samples in Southwest Nigeria. Int J Infect. 2021b;8(4):e114143. https:\/\/doi.org\/10.5812\/iji.114143.","journal-title":"Int J Infect"},{"key":"11169_CR38","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.mcp.2021.101732","volume":"58","author":"SS Abhari","year":"2021","unstructured":"Abhari SS, Azizi O, Modiri L, Aslani MM, Assmar M, Fereshteh S, et al. Two new rapid PCR-based methods for identification of Acinetobacter baumannii isolated from clinical samples. Mol Cell Probes. 2021;58:101732. https:\/\/doi.org\/10.1016\/j.mcp.2021.101732.","journal-title":"Mol Cell Probes"},{"key":"11169_CR39","doi-asserted-by":"publisher","unstructured":"Mlynarcik P, Roderova M, Kolar M. Primer evaluation for PCR and its application for detection of carbapenemases in Enterobacteriaceae. Jundishapur J Microbiol. 2016 January;9(1):e29314. https:\/\/doi.org\/10.5812\/jjm.29314.","DOI":"10.5812\/jjm.29314"},{"issue":"4","key":"11169_CR40","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/jac\/dkr563","volume":"67","author":"J Monteiro","year":"2012","unstructured":"Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. 2012;67(4):906\u20139. https:\/\/doi.org\/10.1093\/jac\/dkr563.","journal-title":"J Antimicrob Chemother"},{"key":"11169_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"A Bauer","year":"1966","unstructured":"Bauer A, Kirby WW, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol. 1966;45:493\u20136.","journal-title":"Am J Clin Pathol"},{"issue":"suppl B","key":"11169_CR42","first-page":"1","volume":"217","author":"HM Ericsson","year":"1971","unstructured":"Ericsson HM, Sherris JC. The agar Dilution method. Acta Pathol Microbiol Scand. 1971;217(suppl B):1\u201390.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"11169_CR43","unstructured":"CLSI. (2024). Performance Standards for Antimicrobial Susceptibility Testing. 34th Edition. CLSI Supplement M100. Clinical and Laboratory Standards Institute, 2024."},{"key":"11169_CR44","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.3389\/fmicb.2018.0239","volume":"9","author":"X Jing","year":"2018","unstructured":"Jing X, Zhou H, Min X, Zhang X, Yang Q, Du S, et al. The simplified carbapenem inactivation method (sCIM) for simple and accurate detection of carbapenemase-Producing Gram-Negative Bacilli. Front Microbiol. 2018;9:2391. https:\/\/doi.org\/10.3389\/fmicb.2018.0239.","journal-title":"Front Microbiol"},{"key":"11169_CR45","doi-asserted-by":"publisher","first-page":"e14831","DOI":"10.7717\/peerj.14831","volume":"11","author":"T Kitti","year":"2023","unstructured":"Kitti T, Manrueang S, Leungtongkam U, Khongfak S, Thummeepak R, Wannalerdsakun S, et al. Genomic relatedness and dissemination of blaNDM-5 among Acinetobacter baumannii isolated from hospital environments and clinical specimens in Thailand. PeerJ. 2023;11:e14831. https:\/\/doi.org\/10.7717\/peerj.14831.","journal-title":"PeerJ"},{"key":"11169_CR46","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.2147\/IDR.S471645","volume":"17","author":"AD Abukhalil","year":"2024","unstructured":"Abukhalil AD, Barakat SA, Mansour A, Al-Shami N, Naseef H. ESKAPE pathogens: antimicrobial resistance patterns, risk factors, and outcomes a retrospective Cross-Sectional study of hospitalized patients in Palestine. Infect Drug Res. 2024;17:3813\u201323. https:\/\/doi.org\/10.2147\/IDR.S471645.","journal-title":"Infect Drug Res"},{"key":"11169_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jiph.2023.01.004","volume":"16","author":"TA Hafiz","year":"2023","unstructured":"Hafiz TA, Alghamdi SS, Mubaraki MA, Alghamdi SSM, Alothaybi A, Aldawood E, et al. A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically ill patients: clinical and Microbiological findings. J Infect Public Health. 2023;16:313\u20139. https:\/\/doi.org\/10.1016\/j.jiph.2023.01.004.","journal-title":"J Infect Public Health"},{"key":"11169_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ajic.2014.03.016","volume":"42","author":"R Rosa","year":"2014","unstructured":"Rosa R, Depascale D, Cleary T, Fajardo-Aquino Y, Kett DH, Munoz-Price LS. Differential environmental contamination with Acinetobacter baumannii based on the anatomic source of colonization. Am J Infect Control. 2014;42:755\u20137. https:\/\/doi.org\/10.1016\/j.ajic.2014.03.016.","journal-title":"Am J Infect Control"},{"key":"11169_CR49","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1017\/ice.2016.69","volume":"37","author":"LA Shimose","year":"2016","unstructured":"Shimose LA, Masuda E, Sfeir M, Berbel Caban A, Bueno MX, de Pascale D, et al. Carbapenem-resistant Acinetobacter baumannii: concomitant contamination of air and environmental surfaces. Infect Control Hosp Epidemiol. 2016;37:777\u201381. https:\/\/doi.org\/10.1017\/ice.2016.69.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"11169_CR50","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jiph.2019.08.013","volume":"13","author":"A Al-Hamad","year":"2020","unstructured":"Al-Hamad A, Pal T, Leskafi H, Abbas H, Hejles H, Alsubikhy F, et al. Molecular characterization of clinical and environmental carbapenem resistant Acinetobacter baumannii isolates in a hospital of the Eastern region of Saudi Arabia. J Infect Public Health. 2020;13:632\u20136. https:\/\/doi.org\/10.1016\/j.jiph.2019.08.013.","journal-title":"J Infect Public Health"},{"key":"11169_CR51","doi-asserted-by":"publisher","first-page":"1045206","DOI":"10.3389\/fmicb.2022.1045206","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Ding Y, Wei Y, Jian C, Liu J, Zeng Z. Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit. Front Microbiol. 2022;13:1045206. https:\/\/doi.org\/10.3389\/fmicb.2022.1045206.","journal-title":"Front Microbiol"},{"issue":"5","key":"11169_CR52","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/00006123-199411000-00008","volume":"35","author":"MH Nguyen","year":"1994","unstructured":"Nguyen MH, Harris SP, Muder RR, Pasculle AW. Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients. Neurosurgery. 1994;35(5):851\u20135. https:\/\/doi.org\/10.1097\/00006123-199411000-00008","journal-title":"Neurosurgery"},{"key":"11169_CR53","doi-asserted-by":"publisher","unstructured":"Aboshakwa AM, Lalla U, Irusen EM, Koegelenberg CFN. Acinetobacter baumannii infection in a medical intensive care unit: the impact of strict infection control. Afr J Thorac Crit Care Med. 2019;25(1). https:\/\/doi.org\/10.7196\/AJTCCM.2019.v25i1.239.","DOI":"10.7196\/AJTCCM.2019.v25i1.239"},{"key":"11169_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/aam.aam_141_23","volume":"23","author":"Y Mohammed","year":"2024","unstructured":"Mohammed Y, Muhammad AS, Zainu SM, Jimoh AK, Olowo\u2013Okere A, Ogunyinka IA, et al. Outbreak of multidrug\u2013resistant Acinetobacter baumannii in a tertiary health center from Northwestern Nigeria. Ann Afr Med. 2024;23:40\u20135. https:\/\/doi.org\/10.4103\/aam.aam_141_23.","journal-title":"Ann Afr Med"},{"key":"11169_CR55","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1590\/0037-8682-0329-2016","volume":"50","author":"OHF Raro","year":"2017","unstructured":"Raro OHF, Gallo SW, Ferreira CAS, Oliveira SD. Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit. Rev Soc Bras Med Trop. 2017;50:167\u201372. https:\/\/doi.org\/10.1590\/0037-8682-0329-2016.","journal-title":"Rev Soc Bras Med Trop"},{"key":"11169_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.medmal.2014.03.005","volume":"44","author":"S Alfandari","year":"2014","unstructured":"Alfandari S, Gois J, Delannoy PY, Georges H, Boussekey N, Chiche A, et al. Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Med Mal Infect. 2014;44:229\u201331. https:\/\/doi.org\/10.1016\/j.medmal.2014.03.005.","journal-title":"Med Mal Infect"},{"issue":"8","key":"11169_CR57","doi-asserted-by":"publisher","first-page":"e104882","DOI":"10.1371\/journal.pone.0104882","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Ruan Z, Feng Y, Fu Y, Jiang Y, Wang H, et al. Species distribution of clinical Acinetobacter isolates revealed by different identification techniques. PLoS ONE. 2014;9(8):e104882. https:\/\/doi.org\/10.1371\/journal.pone.0104882.","journal-title":"PLoS ONE"},{"key":"11169_CR58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.csbj.2022.12.045","volume":"21","author":"J Kabic","year":"2023","unstructured":"Kabic J, Novovic K, Kekic D, Trudic A, Opavski N, Dimkic I, et al. Comparative genomics and molecular epidemiology of colistin-resistant Acinetobacter baumannii. Comput Struct Biotechnol J. 2023;21:574\u201385. https:\/\/doi.org\/10.1016\/j.csbj.2022.12.045.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"11169_CR59","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijantimicag.2017.03.006","volume":"50","author":"A Ahmadi","year":"2017","unstructured":"Ahmadi A, Salimizand H. Delayed identification of Acinetobacter baumannii during an outbreak owing to disrupted blaOXA-51-like by ISAba19. Int J Antimicrob Agents. 2017;50(1):119\u201322. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.03.006.","journal-title":"Int J Antimicrob Agents"},{"key":"11169_CR60","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/1469-0691.12026","volume":"19","author":"X Schleicher","year":"2013","unstructured":"Schleicher X, Higgins PG, Wisplinghoff H, Korber-Irrgang B, Kresken M, Seifert H. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005\u20132009). Clin Microbiol Infect. 2013;19:737\u201342. https:\/\/doi.org\/10.1111\/1469-0691.12026","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"11169_CR61","first-page":"47","volume":"NIJOPHASR9","author":"O Fasuyi","year":"2020","unstructured":"Fasuyi O, Ike WE, Ojo DA, Akinloye OA. Plasmid profile of multidrug-resistant Acinetobacter baumannii strains from wounds of patients attending ederal edical Centre, Abeokuta, Southwest, Nigeria. NIJOPHASR. 2020;NIJOPHASR9(2):47\u201351.","journal-title":"NIJOPHASR"},{"key":"11169_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jgar.2023.02.016","volume":"33","author":"IMM Kim","year":"2023","unstructured":"Kim IMM, Kim J, Kim K, Akter D, Bang S. Complete genome sequence of the multidrug-resistant clinical isolate Acinetobacter baumannii KBN10P05679: insights into antimicrobial resistance genotype and potential virulence traits. J Glob Antimicrob Res. 2023;33:78\u201382. https:\/\/doi.org\/10.1016\/j.jgar.2023.02.016.","journal-title":"J Glob Antimicrob Res"},{"issue":"2","key":"11169_CR63","first-page":"26","volume":"9","author":"WE Ike","year":"2020","unstructured":"Ike WE, Adeniyi BA, Peters JE. Molecular basis of Carbapenem-Resistant Acinetobacter baumannii from Southwest. Nigeria NIJOPHASR. 2020;9(2):26\u201332. https:\/\/nijophasr.net\/index.php\/nijophasr\/article\/view\/340.","journal-title":"Nigeria NIJOPHASR"},{"key":"11169_CR64","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.diagmicrobio.2008.06.008","volume":"62","author":"L Huang","year":"2008","unstructured":"Huang L, Sun L, Xu G, Xia T. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital. Diagn Microbiol Infect Dis. 2008;62:326\u201332.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"11169_CR65","doi-asserted-by":"publisher","unstructured":"Hawkey J, Ascher DB, Judd LM, Wick RR, Kostoulias X, Cleland H, et al. Evolution of carbapenem resistance in Acinetobacter baumannii during a prolonged infection. Microb Genom. 2018;4(3). https:\/\/doi.org\/10.1099\/mgen.0.000165. \/.","DOI":"10.1099\/mgen.0.000165"},{"issue":"11","key":"11169_CR66","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.3390\/biomedicines12112532","volume":"12","author":"B Yousefi","year":"2024","unstructured":"Yousefi B, Kashanipoor S, Mazaheri P, Alibabaei F, Babaeizad A, Asli S, et al. Cefiderocol in combating Carbapenem-Resistant Acinetobacter baumannii: action and resistance. Biomedicines. 2024;12(11):2532. https:\/\/doi.org\/10.3390\/biomedicines12112532.","journal-title":"Biomedicines"},{"issue":"9","key":"11169_CR67","doi-asserted-by":"publisher","first-page":"e30365","DOI":"10.1016\/j.heliyon.2024.e30365","volume":"10","author":"A Desmoulin","year":"2024","unstructured":"Desmoulin A, Sababadichetty L, Kamus L, Daniel M, Feletti L, Allou N, et al.. Adaptive resistance to Cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): Microbiological and clinical issues. Heliyon. 2024;10(9):e30365. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30365","journal-title":"Heliyon"},{"issue":"1","key":"11169_CR68","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1556\/030.2024.02201","volume":"71","author":"T Strateva","year":"2024","unstructured":"Strateva T, Peykov S. First detection of a cefiderocol-resistant and extensively drug-resistant Acinetobacter baumannii clinical isolate in Bulgaria. Acta Microbiol Immunol Hung. 2024;71(1):25\u201336. https:\/\/doi.org\/10.1556\/030.2024.02201.","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"11","key":"11169_CR69","doi-asserted-by":"publisher","first-page":"e01221","DOI":"10.1128\/AAC.01221-20","volume":"64","author":"S Malik","year":"2020","unstructured":"Malik S, Kaminski M, Landman D, Quale J. Cefiderocol resistance in Acinetobacter baumannii: roles of \u03b2-Lactamases, siderophore receptors, and penicillin binding protein 3. Antimicrob Agents Chemother. 2020;64(11):e01221\u201320. https:\/\/doi.org\/10.1128\/AAC.01221-20.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"11169_CR70","first-page":"115","volume":"32","author":"SV Tahbaz","year":"2019","unstructured":"Tahbaz SV, Azimi L, Lari AR. Characterization of aminoglycoside resistance mechanisms in Acinetobacter baumannii isolates from burn wound colonization. Ann Burns Fire Disasters. 2019;32(2):115\u201321.","journal-title":"Ann Burns Fire Disasters"},{"key":"11169_CR71","doi-asserted-by":"publisher","unstructured":"Rizk MA, Abou El-Khier NT. Aminoglycoside resistance genes in Acinetobacter baumannii clinical isolates. Clin Lab. 2019;65(7). https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190103.","DOI":"10.7754\/Clin.Lab.2019.190103"},{"key":"11169_CR72","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12941-021-00480-5","volume":"20","author":"NY Nojookambari","year":"2021","unstructured":"Nojookambari NY, Sadredinamin M, Dehbanipour R, Ghalavand Z, Eslami G, Vaezjalali M, et al. Prevalence of \u03b2\u2013lactamase\u2013encoding genes and molecular typing of Acinetobacter baumannii isolates carrying carbapenemase OXA\u201324 in children. Ann Clin Microbiol Antimicrob. 2021;20:75. https:\/\/doi.org\/10.1186\/s12941-021-00480-5.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"3","key":"11169_CR73","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/jac\/dks448","volume":"68","author":"P Villal\u00f3n","year":"2013","unstructured":"Villal\u00f3n P, Valdezate S, Medina-Pascual MJ, Carrasco G, Vindel A, Saez-Nieto JA. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-\u03b2-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J Antimicrob Chemother. 2013;68(3):550\u20133. https:\/\/doi.org\/10.1093\/jac\/dks448","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"11169_CR74","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/antibiotics8030148","volume":"8","author":"C Hoang Quoc","year":"2019","unstructured":"Hoang Quoc C, Nguyen Thi Phuong T, Nguyen Duc H, Tran Le T, Tran Thi Thu H, Nguyen Tuan S, et al. Carbapenemase genes and multidrug resistance of Acinetobacter Baumannii: A Cross-Sectional study of patients with pneumonia in Southern Vietnam. Antibiotics. 2019;8(3):148. https:\/\/doi.org\/10.3390\/antibiotics8030148.","journal-title":"Antibiotics"},{"key":"11169_CR75","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijantimicag.2015.07.012","volume":"46","author":"S Shrestha","year":"2015","unstructured":"Shrestha S, Tada T, Miyoshi-Akiyama T, Ohara H, Shimada K, Satou K, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage. Int J Antimicrob Agents. 2015;46:526\u201331.","journal-title":"Int J Antimicrob Agents"},{"key":"11169_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13756-017-0180-5","volume":"6","author":"PR Joshi","year":"2017","unstructured":"Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. Co-existence of blaOXA-23 and blaNDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control. 2017;6:21.","journal-title":"Antimicrob Resist Infect Control"},{"key":"11169_CR77","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.meegid.2019.04.022","volume":"73","author":"A Opazo-Capurro","year":"2019","unstructured":"Opazo-Capurro A, Mart\u00edn I, Quezada-Aguiluz M, Morales-Le\u00f3n F, Dom\u00ednguez-Y\u00e9venes M, Lima CA, et al. Evolutionary dynamics of carbapenem-resistant Acinetobacter baumannii Circulating in Chilean hospitals. Infect Genet Evol. 2019;73:93\u20137.","journal-title":"Infect Genet Evol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11169-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11169-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T04:15:40Z","timestamp":1748837740000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11169-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11169"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11169-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Ethics Committee of Health Planning, Research, and Statistics Department of the Osun State Ministry of Health, Osogbo (OSHREC\/PRS\/569T\/482), and all procedure in the study complied with the Helsinki Declaration of 1975 (in its most recently amended version). Informed consent was obtained from each participant, and parental informed consent was sought from the parents\/guardians of children below 18 years.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"786"}}